Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
Hussain
Hadi Meeran
HM
Zakria
Manzar
M
Arshad
Abdul Rehman
AR
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism / Q000473:pathology*; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000378:metabolism; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology*; D003072:Cognition Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology*; D015331:Cohort Studies; D003627:Data Interpretation, Statistical; D004660:Encephalitis / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000145:classification / Q000627:therapeutic use*; D015994:Incidence; D017063:Outcome Assessment, Health Care / Q000379:methods; D015203:Reproducibility of Results
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors